Nuevos Eticos Neoethicals, S.a. Pharmaceutical Import Profile — Guatemala (DGFT 2022–2026)

Name: Nuevos Eticos Neoethicals, S.a. Pharmaceutical Import Records from India — 23 Products, $39.9M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Nuevos Eticos Neoethicals, S.a. — Pharmaceutical Importer Profile (2026) | 23 Products, $39.9M Trade | TransData Nexus

Nuevos Eticos Neoethicals, S.a.

Pharmaceutical Importer · Guatemala · Analgesics & Antipyretics Focus · $39.9M Total Trade · DGFT Verified

Nuevos Eticos Neoethicals, S.a. is a pharmaceutical importer based in Guatemala with a total trade value of $39.9M across 23 products in 10 therapeutic categories. Based on 883 verified import shipments from Indian Customs (DGFT) records, Nuevos Eticos Neoethicals, S.a. is the #1 buyer in 2 products including Clotrimazole, Secnidazole. Nuevos Eticos Neoethicals, S.a. sources from 3 verified Indian suppliers, with Caplin Point Laboratories Limited accounting for 98.7% of imports.

Nuevos Eticos Neoethicals, S.a. — Import Portfolio & Supplier Network

Nuevos Eticos Neoethicals, S.a. import network — 23 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Nuevos Eticos Neoethicals, S.a.?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Caplin Point Laboratories Limited	$14.7M	601	98.7%
Argus Salud Pharma Llp	$131.4K	4	0.9%
Caplin One Labs Limited	$61.4K	2

What Formulations Does Nuevos Eticos Neoethicals, S.a. Import?

Formulation	Value	Ships
Ibuprofen tablets BP 800MG	$522.7K	15
Ibuwin forte ibuprofen soft gelatin capsules 800MG	$395.3K	10
Ibuwin 600 ibuprofen soft gelatin capsules 600MG	$394.6K	9
Gencloben 30GM gentamycin betamethasoneclotrimazole cream gencloben 30ggentamicina+betametasona + clotrimazol	$293.1K	7
Secnidazole tablets 500MG	$255.3K	7
Diclofenac sodium + neurotropas soft	$200.0K	4
Candesartan cilexetil tablets USP 32MG	$200.0K	4
Albendazole chewable tablets 400MG	$187.3K	8
Ibuprofen soft gelatin capsules 800MG	$178.9K	4
Diclofenac potassium tablets USP 50MG	$175.3K	4
Ibuprofen tablets BP 600MG	$166.6K	6
Losartan potassium tablets USP 50MG	$165.9K	5
Fluconazole capsules USP 200MG	$162.0K	7
Gabapentin capsules USP 400MG	$158.0K	5
Cefadroxil tablets USP 500MG cefadroxilo500mg	$153.1K	4

Nuevos Eticos Neoethicals, S.a. imports 345 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 23 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Ibuprofen	Analgesics & Antipyretics	$7.5M	149	1.3%	7
2	Clotrimazole	Antifungals	$4.6M	109	4.1%	1
3	Diclofenac	Analgesics & Antipyretics	$4.2M	84	1.2%	7
4	Vitamin	Nutritional Supplements	$3.5M	79	1.7%	4
5	Lansoprazole	Gastrointestinal	$2.8M	55	0.9%	5
6	Acetaminophen	Analgesics & Antipyretics	$2.2M	44	0.9%	7
7	Amino	Nutritional Supplements	$2.2M	44	0.7%	9
8	Gentamicin	Antibiotics	$2.1M	58	2.9%	3
9	Irbesartan	Cardiovascular	$2.0M	40	1.9%	5
10	Secnidazole	Advanced Antibiotics	$1.9M	39	5.0%	1
11	Hydrochlorothiazide	Diuretics	$1.6M	32	0.4%	12
12	Heparin	Cardiovascular	$1.1M	22	0.3%	3
13	Azithromycin	Antibiotics	$900.0K	18	0.5%	9
14	Potassium	Nutritional Supplements	$750.0K	15	0.1%	17
15	Ketoconazole	Antifungals	$589.8K	17	1.5%	13
16	Amoxicillin	Antibiotics	$550.0K	11	0.1%	12
17	Albendazole	Antimalarial & Antiparasitic	$459.4K	35	0.6%	15
18	Ranitidine	Gastrointestinal	$292.0K	9	2.3%	7
19	Lactulose	Gastrointestinal	$247.7K	6	1.8%	6
20	Sunitinib	Advanced Oncology	$200.0K	4	0.3%	12
21	Collagen	Nutritional Supplements	$193.1K	7	3.9%	4
22	Dasatinib	Advanced Oncology	$150.0K	3	0.9%	10
23	Lapatinib	Advanced Oncology	$12.3K	3	0.2%	6

Nuevos Eticos Neoethicals, S.a. imports 23 pharmaceutical products across 10 categories into Guatemala totaling $39.9M. The company is the #1 buyer for 2 products: Clotrimazole, Secnidazole.

Nuevos Eticos Neoethicals, S.a. — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Nuevos Eticos Neoethicals, S.A. (NEOETHICALS) is a Guatemalan pharmaceutical importer and wholesaler established on November 16, 2004. Operating under the commercial name "NEOETHICALS," the company specializes in the wholesale distribution of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Headquartered at 10a Calle 27-67 Zona 4 Col. El Naranjo Bodega No. 4 y 5, Mixco, Guatemala, NEOETHICALS plays a pivotal role in the Guatemalan pharmaceutical supply chain by sourcing and distributing a diverse range of pharmaceutical products to meet the country's healthcare needs.

2Distribution Network

NEOETHICALS operates its distribution center at the aforementioned address in Mixco, Guatemala. While specific details about additional warehouse locations and logistics capabilities are not publicly disclosed, the company's strategic location in Mixco suggests a centralized distribution model aimed at efficiently serving the Guatemalan market. The company's import activities, including shipments from India, indicate a focus on international sourcing to meet domestic demand.

3Industry Role

As a primary wholesaler, NEOETHICALS imports and distributes a wide array of pharmaceutical products within Guatemala. The company's extensive participation in public contracts, including those with the Guatemalan Institute of Social Security (IGSS) and the Ministry of Public Health, underscores its significant role in supplying essential medications to both public and private healthcare sectors. (sociedad.info)

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Nuevos Eticos Neoethicals, S.a.

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

NEOETHICALS demonstrates a high degree of sourcing concentration, with 98.7% of its imports from India supplied by Caplin Point Laboratories Limited. This single-source dependency may pose risks related to supply chain disruptions or changes in supplier terms. However, the consistent volume of shipments and the company's substantial import value from India suggest a stable and strategic partnership with Caplin Point Laboratories Limited. The remaining 1.3% of imports are sourced from two other Indian suppliers, indicating a diversified yet limited supplier base.

2Supply Chain Resilience

NEOETHICALS' reliance on a single primary supplier, Caplin Point Laboratories Limited, could impact supply chain resilience. The company's import data reveals a focus on a limited number of formulations, with 345 unique formulations imported. This suggests a strategic approach to product selection, potentially reducing complexity and enhancing supply chain efficiency. However, the limited number of suppliers may expose the company to risks associated with supplier-specific disruptions.

3Strategic Implications

Importing Pharmaceuticals into Guatemala — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Guatemala

1Regulatory Authority & Framework

In Guatemala, the Ministry of Public Health and Social Assistance (MSPAS) is the primary regulatory authority overseeing pharmaceutical imports. Key legislation governing pharmaceutical imports includes the Pharmaceutical Law and the Regulations for the Registration of Pharmaceutical Products. The marketing authorization pathway for Indian generics involves obtaining registration from the MSPAS, which requires submission of comprehensive documentation, including proof of Good Manufacturing Practice (GMP) compliance, product dossiers, and stability data.

2Import Licensing & GMP

Import licensing in Guatemala necessitates obtaining an import permit from the MSPAS, which involves demonstrating compliance with GMP standards recognized by the World Health Organization (WHO) or the Pan American Health Organization (PAHO). Indian exporters must ensure that their manufacturing facilities hold valid GMP certifications from recognized authorities to meet these requirements. Additionally, wholesalers like NEOETHICALS must possess a valid wholesale distribution authorization issued by the MSPAS to legally distribute pharmaceutical products within the country.

3Quality & Labeling

Nuevos Eticos Neoethicals, S.a. — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

NEOETHICALS' focus on analgesics and antipyretics (34.7%), nutritional supplements (16.6%), and antifungals (13.0%) aligns with prevalent health concerns in Guatemala, such as pain management, nutritional deficiencies, and fungal infections. The company's import strategy is driven by market demand for these therapeutic areas, indicating a responsive approach to the healthcare needs of the Guatemalan population.

2Sourcing Profile

NEOETHICALS' sourcing strategy emphasizes generic drugs, particularly in the analgesic, antifungal, and nutritional supplement categories. The company's preference for formulations with established efficacy and safety profiles reflects a focus on cost-effective solutions to meet widespread health issues. India's robust pharmaceutical manufacturing sector, known for producing high-quality generics, aligns well with NEOETHICALS' procurement needs.

3Market Positioning

NEOETHICALS serves a broad segment of the Guatemalan pharmaceutical market, including retail pharmacies, hospitals, and government tenders. The company's extensive participation in public contracts, such as those with the IGSS and the Ministry of Public Health, underscores its significant role in supplying essential medications to both public and private healthcare sectors. (sociedad.info)

Seller's Guide — How to Become a Supplier to Nuevos Eticos Neoethicals, S.a.

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter NEOETHICALS' supply chain, particularly if they can offer competitive pricing, reliable delivery, and high-quality products. Diversifying the supplier base could mitigate risks associated with over-reliance on a single source and enhance supply chain resilience. Identifying gaps in NEOETHICALS' current sourcing, such as unmet therapeutic needs or emerging market trends, could provide avenues for new suppliers to introduce innovative products.

2Requirements & Qualifications

Indian exporters aiming to supply NEOETHICALS and the Guatemalan market must ensure their manufacturing facilities hold valid GMP certifications from recognized authorities, such as the WHO or PAHO. Compliance with Guatemalan import regulations, including obtaining necessary import permits and adhering to labeling requirements, is essential. Additionally, maintaining a robust quality management system and providing comprehensive product documentation will facilitate smoother market entry.

3How to Approach

Frequently Asked Questions — Nuevos Eticos Neoethicals, S.a.

What products does Nuevos Eticos Neoethicals, S.a. import from India?

Nuevos Eticos Neoethicals, S.a. imports 23 pharmaceutical products across 10 categories. Top imports: Ibuprofen ($7.5M), Clotrimazole ($4.6M), Diclofenac ($4.2M), Vitamin ($3.5M), Lansoprazole ($2.8M).

Who supplies pharmaceuticals to Nuevos Eticos Neoethicals, S.a. from India?

Nuevos Eticos Neoethicals, S.a. sources from 3 verified Indian suppliers. The primary supplier is Caplin Point Laboratories Limited (98.7% of imports, $14.7M).

What is Nuevos Eticos Neoethicals, S.a.'s total pharmaceutical import value?

Nuevos Eticos Neoethicals, S.a.'s total pharmaceutical import value from India is $39.9M, based on 883 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Nuevos Eticos Neoethicals, S.a. focus on?

Nuevos Eticos Neoethicals, S.a. imports across 10 categories. The largest: Analgesics & Antipyretics (34.7%), Nutritional Supplements (16.6%), Antifungals (13.0%).

Get Full Nuevos Eticos Neoethicals, S.a. Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 3 company name variants from customs records. For current shipment-level data, contact TransData Nexus.